Roadzen Inc. current report, 28 March 2024

Full document

Roadzen Inc. Form 8-K Summary

Business context and reporting period

Roadzen Inc. filed a Current Report on Form 8-K dated April 3, 2024, reporting an agreement entered into on March 28, 2024. The filing concerns a financing transaction rather than periodic operating results. Roadzen is incorporated in the British Virgin Islands and its ordinary shares and warrants trade on Nasdaq under the symbols RDZN and RDZNW.

Financing and key financial terms

  • Roadzen entered into a Securities Purchase Agreement with Supurna VedBrat and Krishnan-Shah Family Partners, LP, related parties that include company directors and their family members.
  • The purchasers initially purchased an aggregate of $1.0 million of senior secured notes: $500,000 from each purchaser.
  • Each purchaser may be required to purchase an additional $500,000 of notes, subject to specified conditions, potentially increasing the transaction to $2.0 million.
  • Roadzen may also issue up to an additional $2.0 million of notes to other purchasers under the agreement.
  • The notes bear interest at 17.5% annually and mature six months after the applicable funding date.
  • Interest may generally be paid in cash or in kind through the issuance of ordinary shares during the initial six-month period. The filing does not provide a current share count or a fixed conversion price.
  • If principal and accrued interest are not repaid at maturity, the rate increases to 19.5% and rises by 200 basis points monthly, up to a maximum of 29.5%. Unpaid amounts become payable within five business days after written demand.
  • The notes are intended to rank senior to the company’s other indebtedness, except outstanding indebtedness to Mizuho Securities USA LLC, and are to be secured by company and subsidiary assets, subject to existing Mizuho liens.
  • The notes restrict additional indebtedness and liens, subject to specified exceptions, and include customary events of default.

Warrants and securities issuance

  • For each $10,000 of notes purchased, the company agreed to issue warrants to purchase 1,000 ordinary shares.
  • The warrants are exercisable from March 28, 2025 through March 28, 2031, unless earlier terminated by a company dissolution, liquidation, or winding up.
  • The exercise price will equal 80% of the lowest of specified market or offering-price measurements. The filing does not provide a definitive exercise price.
  • The company agreed to enter into a registration rights agreement for the warrant shares within 30 days of March 28, 2024.
  • The notes, warrants, and related ordinary shares were offered under private-placement exemptions pursuant to Securities Act Section 4(a)(2) and Rule 506 of Regulation D.

Material changes, outlook, risks, and unusual items

  • The transaction creates at least $1.0 million of new senior secured debt and could create additional debt of up to $4.0 million under the SPA, including potential additional purchases by the existing purchasers and other investors.
  • The high interest rate, escalating default-related rate provisions, short six-month maturity, and demand repayment feature may create significant liquidity and refinancing risk.
  • Payment of interest in kind could increase indebtedness and dilute existing shareholders through share issuance.
  • The warrant terms may also result in substantial future dilution, with the number of warrants based on funded principal and an exercise price set at a discount to specified market or offering prices.
  • Subsidiary guarantees, security interests, reporting requirements, and other transaction conditions must be completed or satisfied, with security arrangements subject to Mizuho approval and existing liens.
  • The filing provides no revenue, profit, cash flow, margin, cash balance, or operating guidance data for the reported period.
  • The warrants had not yet been issued as of the filing; the company stated that the warrant form would be filed in an amendment to the Form 8-K.

Investor verification items

  • Verify the final amount of notes funded, including whether the potential additional $1.0 million from the existing purchasers and up to $2.0 million from other purchasers was completed.
  • Review the executed notes, security and pledge documents, subsidiary guarantees, and Mizuho’s existing liens and consent rights.
  • Confirm the final warrant issuance, warrant count, exercise price, registration rights agreement, and potential dilution.
  • Assess Roadzen’s cash resources and ability to repay the notes and accrued interest at the six-month maturity or upon demand thereafter.
  • Review the related-party nature of the financing and the company’s disclosure of director participation.